HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Mobile Intervention to Improve Uptake of PrEP for Southern Black MSM [NA]
Clinical trial update on a mobile intervention to improve uptake of PrEP for Southern Black men who have sex with men; study completed with …
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Glutathione and Function in HIV Patients [Phase 1]
Phase 1 clinical trial assessing glutathione and function in HIV patients has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine [Phase 1, Phase 2]
Safety and immunogenicity results from a Phase 1/2 trial of a clade C ALVAC-HIV vaccine with gp120 were reported; the study has completed wi…
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Expanded PrEP Implementation in Communities in NSW [Phase 3]
Phase 3 trial update on expanded PrEP implementation in NSW communities; study completed.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults [Phase 2]
Phase 2 proof-of-concept study of GSK3640254 in treatment-naive adults with HIV-1 completed; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-02-11FDA Approved: BIKTARVY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental NDA for BIKTARVY from Gilead Sciences, expanding or updating its labeling and/or indication.
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF) [Phase 4]
Phase 4 trial evaluating how Ledipasvir/Sofosbuvir affects the pharmacokinetics and renal safety of Tenofovir Alafenamide in patients with h…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART [Phase 1, Phase 2]
Phase 1/2 trial evaluating repeat dosing of SB-728mR-T after cyclophosphamide conditioning in HIV-infected individuals on HAART has complete…
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL [Phase 2]
Phase 2 ANRS 163 ETRAL trial evaluates whether dual therapy with raltegravir and etravirine maintains virological suppression in HIV-1–infec…
-
FDA approval · 2021-02-05FDA Approved: BIKTARVY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for BIKTARVY, confirming regulatory clearance for this HIV-1 treatment regimen developed by Gile…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant [Phase 4]
Phase 4 trial update on sofosbuvir-based direct-acting antiviral therapy for HIV/HCV coinfected patients before or after liver transplant; s…
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI Resistance [Phase 4]
Phase 4 HIV switch trial in experienced patients with multiple class resistance including NNRTI resistance.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Bangkok Tenofovir Study, an HIV Pre-exposure Prophylaxis Trial, Bangkok, Thailand [Phase 2, Phase 3]
Phase 2/3 trial update for Bangkok Tenofovir Study evaluating HIV pre-exposure prophylaxis; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection [Phase 2, Phase 3]
A phase 2/3 clinical trial update on the INSTI HIV-1 Antibody Test Kit in volunteers at risk for HIV infection.
-
FDA approval · 2021-01-26FDA Approved: LAMIVUDINE — Supplemental Application (Apotex Corp.)
FDA approves a supplemental abbreviated new drug application for Lamivudine from Apotex Corp., authorizing the continued manufacture and dis…
-
FDA approval · 2021-01-21FDA Approved: VOCABRIA — Original Application (ViiV Healthcare Company)
FDA approved VOCABRIA (cabotegravir sodium) through an original drug application from ViiV Healthcare. The approval establishes cabotegravir…
-
FDA approval · 2021-01-21FDA Approved: CABENUVA — Original Application (ViiV Healthcare Company)
The FDA approved CABENUVA (cabotegravir and rilpivirine) as the original approval for a long-acting injectable regimen to treat HIV-1 infect…
-
FDA approval · 2021-01-21FDA Approved: EDURANT — Supplemental Application (Janssen Products, LP)
FDA approved a supplemental application for EDURANT (rilpivirine hydrochloride) submitted by Janssen Products, LP.
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study [Phase 2]
Phase 2b, open-label rollover trial assessing the antiviral activity and safety of long-acting cabotegravir plus long-acting rilpivirine giv…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Smoking Cessation Using Motivational Therapy and Varenicline [NA]
A completed clinical trial evaluating motivational therapy alongside varenicline for smoking cessation in individuals with HIV infections.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients [Phase 2]
Phase 2 clinical trial update evaluating the efficacy and safety of the GnRH analogue triptorelin for reducing HIV-1 reservoirs in ART-treat…
-
FDA approval · 2021-01-13FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Strides Pharma Science Limited)
FDA approved a generic fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate under an original ANDA from Strides Pharma …
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2-Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated emtricitabine/tenofovir alafenamide (F/TAF) in HIV-1 infected children and adolescents who were virolog…
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Triggered Escalating Real-time Adherence (TERA) Intervention [NA]
Completed clinical trial of the TERA intervention for HIV infection; results posted in 2021. No phase information available.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus [Phase 2]
Phase 2 trial evaluating GS-9131 monotherapy in HIV-1-infected adults failing a NRTI-containing regimen with NRTI-resistant virus; study ter…